TY - JOUR
T1 - Early clinical outcomes of new pediatric extracorporeal life support system (Endumo® 2000) in neonates and infants
AU - Hoashi, Takaya
AU - Kagisaki, Koji
AU - Yamashita, Kizuku
AU - Tatsumi, Eisuke
AU - Nishigaki, Takayuki
AU - Yoshida, Kotaro
AU - Hayashi, Teruyuki
AU - Ichikawa, Hajime
PY - 2013/9
Y1 - 2013/9
N2 - We investigated early clinical outcomes of a new extracorporeal life support (ECLS) system (Endumo® 2000, Heiwa Bussan, Tokyo, Japan), which consists of a ROTAFLOW centrifugal pump, a BIOCUBE oxygenator with plasma-leakage-tight polymer fibers, and a biocompatible coating (T-NCVC ® coating), in pediatric patients <1 year old. From 2008 to 2011, 31 patients required ECLS. Except for 1 patient who was instituted with a transitional ECLS device, a conventional ECLS system (pediatric Emersave ®, TERUMO, Saitama, Japan) was initiated in 14 patients before December 2009 (6 boys, 63.4 ± 87.1 days old, 3.1 ± 1.0 kg), and the Endumo® 2000 was initiated in 16 patients after December 2009 (8 boys, 43.9 ± 78.5 days old, 3.2 ± 0.7 kg). Primary reasons for the institution of ECLS were intraoperative low output syndrome in 11 patients, post-cardiotomy cardiopulmonary collapse in 9 patients, and other reasons in 10 patients. The median support period was 21.7 ± 20.7 days and the total number of circuit exchanges was 83. The median first circuit durability was significantly longer in the Endumo group [8.0 days (range 5.9-13.2) vs. 4.4 days (1.9-8.3)] (p = 0.020). Significant cranial hemorrhage occurred in only 1 patient, who received the Emersave system. The success rate for weaning from ECLS was 14.3 % in the Emersave group and 56.3 % in the Endumo group. Univariate analysis showed that usage of the Endumo® 2000 was a predictor for successful weaning from the ECLS (p = 0.017) as well as survival at discharge (p = 0.032). The Endumo® 2000 system provided safe and effective cardiopulmonary support without complications.
AB - We investigated early clinical outcomes of a new extracorporeal life support (ECLS) system (Endumo® 2000, Heiwa Bussan, Tokyo, Japan), which consists of a ROTAFLOW centrifugal pump, a BIOCUBE oxygenator with plasma-leakage-tight polymer fibers, and a biocompatible coating (T-NCVC ® coating), in pediatric patients <1 year old. From 2008 to 2011, 31 patients required ECLS. Except for 1 patient who was instituted with a transitional ECLS device, a conventional ECLS system (pediatric Emersave ®, TERUMO, Saitama, Japan) was initiated in 14 patients before December 2009 (6 boys, 63.4 ± 87.1 days old, 3.1 ± 1.0 kg), and the Endumo® 2000 was initiated in 16 patients after December 2009 (8 boys, 43.9 ± 78.5 days old, 3.2 ± 0.7 kg). Primary reasons for the institution of ECLS were intraoperative low output syndrome in 11 patients, post-cardiotomy cardiopulmonary collapse in 9 patients, and other reasons in 10 patients. The median support period was 21.7 ± 20.7 days and the total number of circuit exchanges was 83. The median first circuit durability was significantly longer in the Endumo group [8.0 days (range 5.9-13.2) vs. 4.4 days (1.9-8.3)] (p = 0.020). Significant cranial hemorrhage occurred in only 1 patient, who received the Emersave system. The success rate for weaning from ECLS was 14.3 % in the Emersave group and 56.3 % in the Endumo group. Univariate analysis showed that usage of the Endumo® 2000 was a predictor for successful weaning from the ECLS (p = 0.017) as well as survival at discharge (p = 0.032). The Endumo® 2000 system provided safe and effective cardiopulmonary support without complications.
UR - http://www.scopus.com/inward/record.url?scp=84885429403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885429403&partnerID=8YFLogxK
U2 - 10.1007/s10047-013-0713-5
DO - 10.1007/s10047-013-0713-5
M3 - Article
C2 - 23719779
AN - SCOPUS:84885429403
SN - 1434-7229
VL - 16
SP - 267
EP - 272
JO - Journal of Artificial Organs
JF - Journal of Artificial Organs
IS - 3
ER -